Novartis India Debuts Pluvicto for Prostate Cancer Management
Novartis India has initiated the availability of Pluvicto in the country. This therapeutic agent is intended for addressing prostate cancer patients, marking a significant development in oncology.
Source: The Hindu - Business
Test yourself on today's current affairs
A free daily quiz built from the day's updates, plus civil-engineering mock tests and previous-year papers.
See All Current Affairs →More in National Affairs
Cabinet Renames NSAP to PMSSY, Approves Rs 53,428 Crore for 5 Years
16 October 2026
SDAL Delivers 450 Nagastra-1R Loitering Munitions to Indian Army
16 October 2026
Lakshadweep becomes India's first 100% literate UT under ULLAS scheme
15 October 2026
Indian Coast Guard inducts indigenous ALH MK-III Helicopter in Maharashtra
15 October 2026
PM GatiShakti National Master Plan completes five years of implementation
15 October 2026
West Bengal launches ‘Bhagini Nivedita Scheme’ for unmarried women
15 October 2026